Golimumab, a New, Human, TNF-alpha Antibody Administered Subcutaneously Every 4 Weeks, in Ankylosing Spondylitis: 104-Week Efficacy and Safety Results of the Randomized, Placebo-Controlled GO-RAISE Study
| Autor: | Braun, J., Heijde, D. van der, Deodhar, A., Diekman, L., Sieper, J., Kim, S.I., Beutler, A., Mack, M., Xu, S., Zrubek, J., Hsu, B., Inman, R. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2010 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|